Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Bayer Group Diagnostics — Predicate Candidate Screening
2 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K020210 | GLUCOMETER DEX BLOOD GLUCOSE SYSTEM (MODIFIED) | Bayer Group Diagnostics | 2002-04-30 | 98 | 0 |
| K020208 | GLUCOMETER ELITE DIABETES CARE SYSTEM (MODIFIED) | Bayer Group Diagnostics | 2002-04-29 | 97 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda